Groupe la Francaise’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63K Sell
50
-295
-86% -$23.8K ﹤0.01% 475
2026
Q1
$26K Sell
345
-110,171
-100% -$10.6M ﹤0.01% 404
2025
Q4
$10.6M Buy
110,516
+2,712
+3% +$263K 0.15% 94
2025
Q3
$10.2M Buy
107,804
+91,384
+557% +$8.4M 0.14% 94
2025
Q2
$1.22M Buy
+16,420
New +$1.39M 0.02% 256

Other funds holding MDT

Groupe la Francaise's MDT Position: Q2 2026 in Review

Groupe la Francaise reduced its Medtronic (MDT) stake by 86% in Q2 2026, selling an estimated $23.8K and leaving 50 shares worth $3.63K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Groupe la Francaise first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.6M in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Groupe la Francaise held 50 shares of Medtronic worth $3.63K as of Q2 2026.
  • Groupe la Francaise sold 295 Medtronic shares in Q2 2026, an estimated $23.8K.
  • Medtronic made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #475 holding.
  • Groupe la Francaise first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • Groupe la Francaise's Medtronic position peaked at $10.6M in Q4 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.